Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Malignant Melanoma

  Free Subscription


2 Br J Dermatol
1 Cutis
2 Eur J Dermatol
2 J Am Acad Dermatol
1 J Invest Dermatol
4 Melanoma Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Br J Dermatol

  1. AMBRA1 and loricrin as a test to identify low-risk early-stage melanoma.
    Br J Dermatol. 2024;190:e46.

  2. International trends in the incidence of cutaneous squamous cell carcinoma and melanoma.
    Br J Dermatol. 2024;190:e40.


  3. MANIACI JL, Raghavan SS
    PRAME Expression in Melanocytic Proliferations in Special Sites.
    Cutis. 2024;113:43-47.
    PubMed         Abstract available

    Eur J Dermatol

  4. SONG T, Tan C, Liu Y, Xue YN, et al
    Dermoscopic and reflectance confocal microscopy features of Netherton syndrome.
    Eur J Dermatol. 2023;33:696-697.

  5. LANGBOUR C, Law-Wan J, Ben-Saad R, Zaragoza J, et al
    Intramedullary spinal cord metastasis: a rare complication of malignant melanoma.
    Eur J Dermatol. 2023;33:694-696.

    J Am Acad Dermatol

  6. MATTHEWS NH, Hamad J, Henderson JB, Weinstock MA, et al
    Projected burden of melanoma clinical surveillance in the United States.
    J Am Acad Dermatol. 2024 Mar 8:S0190-9622(24)00476.

  7. TUPPER CJ, Clausen MC, Cogua LM, Silberstein PT, et al
    Improved Survival Outcomes for Melanoma of Unknown Primary in the Era of Novel Therapies: A Population-Based Retrospective Analysis.
    J Am Acad Dermatol. 2024 Mar 6:S0190-9622(24)00446.

    J Invest Dermatol

  8. MOHAMMED NBB, Lau LS, Souchak J, Qiu S, et al
    Tumor-intrinsic galectin-3 suppresses melanoma metastasis.
    J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00169.
    PubMed         Abstract available

    Melanoma Res

  9. NEKKANTI SS, Nusrath S, Jarang R, Rayani BK, et al
    Feasibility and efficacy of indocyanine green in monitoring systemic drug leakage during isolated limb perfusion for recurrent melanoma of extremity.
    Melanoma Res. 2024 Mar 15. doi: 10.1097/CMR.0000000000000967.
    PubMed         Abstract available

  10. LEROY M, Desmedt E, Deramoudt L, Vasseur M, et al
    Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanoma.
    Melanoma Res. 2024 Mar 15. doi: 10.1097/CMR.0000000000000965.
    PubMed         Abstract available

  11. WANG P, Liu T, Zhang Q, Luo P, et al
    Genetic causal relationship between gut microbiota and cutaneous melanoma: a two-sample Mendelian randomization study.
    Melanoma Res. 2024 Mar 11. doi: 10.1097/CMR.0000000000000960.
    PubMed         Abstract available

  12. NG CA, Luckett T, Mulhern B, Kee D, et al
    What matters most to people with metastatic uveal melanoma? A qualitative study to inform future measurement of health-related quality of life.
    Melanoma Res. 2024 Mar 5. doi: 10.1097/CMR.0000000000000961.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.